Cancer gene therapy: Part 2. Candidate transgenes and their clinical development

Kevin J. Harrington*, Alan A. Melcher, Andrew R. Bateman, Atique Ahmed, Richard G. Vile

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer gene therapy: Part 2. Candidate transgenes and their clinical development'. Together they form a unique fingerprint.